Eric Pauwels

CIK 1323212 · CHIEF BUSINESS OFFICER · last filed 2026-02-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.81M

Companies

3

Total Filings

47

Lifetime Open-Market Net

-$11.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PTCT CHIEF BUSINESS OFFICER 77,122 $75.14 $5.79M -$11.03M 35 2026-02-20
NPS PHARMACEUTICALS INC (NPSP) Delisted President, NPS Pharma Int'l 0 $0 11 2015-02-24
ARAY SVP Chief Marketing Officer 30,000 $0.34 $10.2K $0 1 2011-03-01

Recent Filings · Page 2 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-01-07 PTCT Grant (A) +22,000 $0 EDGAR
2024-04-19 PTCT Sell (S) −787 -$19.8K EDGAR
2024-02-16 PTCT Grant (A) +24,300 $0 EDGAR
2024-02-01 PTCT Sell (S) −366 -$10.0K EDGAR
2024-01-10 PTCT Sell (S) −3,634 -$104.9K EDGAR
2023-05-23 PTCT Sell (S) −8,416 -$496.3K EDGAR
2023-05-19 PTCT Sell (S) −8,836 -$517.1K EDGAR
2023-04-20 PTCT Sell (S) −732 -$38.1K EDGAR
2023-02-02 PTCT Sell (S) −375 -$17.1K EDGAR
2023-01-26 PTCT Sell (S) −359 -$17.0K EDGAR
Showing 1120 of 47
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.